alexa Characterization of Phenotype and Genotype of Biofield Treated Enterobacter aerogenes | OMICS International
ISSN: 2161-1025
Translational Medicine

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Characterization of Phenotype and Genotype of Biofield Treated Enterobacter aerogenes

Mahendra Kumar Trivedi1, Alice Branton1, Dahryn Trivedi1, Gopal Nayak1 Mayank Gangwar2 and Snehasis Jana2*

1Trivedi Global Inc., 10624 S Eastern Avenue Suite A-969, Henderson, NV 89052, USA

2Trivedi Science Research Laboratory Pvt. Ltd., Hall-A, Chinar Mega Mall, Chinar Fortune City, Hoshangabad Rd, Bhopal-462026, Madhya Pradesh, India

*Corresponding Author:
Jana S
Trivedi Science Research Laboratory Pvt. Ltd.
Hall-A, Chinar Mega Mall, Chinar Fortune City
Hoshangabad Rd, Bhopal-462026
Madhya Pradesh, India
Tel: +91-755-6660006
E-mail: [email protected]

Received Date: August 15, 2015; Accepted Date: September 02, 2015; Published Date: September 12, 2015

Citation: Trivedi MK, Branton A, Trivedi D, Gangwar GNM, Jana S (2015) Characterization of Phenotype and Genotype of Biofield Treated Enterobacter aerogenes. Transl Med 5:155. doi:10.4172/2161-1025.1000155

Copyright: © 2015 Trivedi MK, et al., This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Translational Medicine

Abstract

Enterobacter aerogenes (E. aerogenes) has been commonly described as a versatile opportunistic pathogen in hospital infections. The aim of the present work was to evaluate the impact of biofield treatment on E. aerogenes for its phenotypic and genotypic characteristics. E. aerogenes bearing ATCC 13048 (American Type Culture Collection) was procured from Bangalore Genei, in sealed pack and divided into control and treated groups. Treated group was subjected to Mr. Trivedi’s biofield treatment and analyzed for antimicrobial susceptibility, minimum inhibitory concentration (MIC), biochemical reactions, and biotype using automated MicroScan Walk-Away® system. In addition, treated group of E. aerogenes was evaluated for DNA polymorphism by Random Amplified Polymorphic DNA (RAPD) and 16S rDNA sequencing to establish the phylogenetic relationship of E. aerogenes with different closely related bacterial species. Antimicrobial susceptibility results showed an alteration of 14.28% among twenty-eight tested antimicrobials. Similarly, 15.65% tested antimicrobials showed an alteration in MIC values. Chloramphenicol showed improved sensitivity i.e. resistant to susceptible after biofield treatment, with the support of decreased MIC by two folds (i.e. >16 to ≤8 μg/mL). Norfloxacin also showed decrease MIC by two folds (i.e. 8 to ≤4 μg/mL) as compared to control. Biofield treatment showed an impact on biochemical reactions (9.09%) followed by a change in biotype number (7770 5272) in treated group with respect to control (7770 5372). Using RAPD analysis, sample showed an average range of 4 to 42% of polymorphism, while 16S rDNA study showed that treated sample was detected as Kluyvera cryocrescens (GenBank Accession Number: AM184245) with 97% identity of gene sequencing data, which was nearest homolog species to Enterobacter aerogenes strain: C1111 (Accession No. AB244467). These results suggest that Mr. Trivedi’s unique biofield treatment can alter the antimicrobial sensitivity pattern, thus it can be used as alternate energy medicine in future.

Keywords

Enterobacter aerogenes, Biofield treatment; Phenotyping, Polymorphism; RAPD; 16S rDNA analysis

Introduction

Enterobacter aerogenes (E. aerogenes) is a common organism of most of the hospital-acquired infections. Adaptive capability of E. aerogenes is remarkable and can easily acquire resistance to against β-lactam antibiotics [1]. During last five years, it has shown that E. aerogenes isolates are having natural resistance against aminopenicillins, and express an extended-spectrum β-lactamase (ESBL), which results resistance to β-lactam antibiotics [2]. However, E. aerogenes exhibits acquired resistance against different categories of antimicrobial agents. General resistance mechanisms exhibited by E. aerogenes involves membrane permeability, p-glycoprotein efflux pump, and enzyme degradation against carbapenems, fluoroquinolones, quinolones, tetracycline, and chloramphenicol [3]. Currently, colistin, and polymyxin antibiotic have been preferred as alternative drugs against Gram-negative pathogens, due to the extended resistance of Gramnegative bacteria against almost all antibiotics [4]. Recently, colistin in antibiotic therapy shows serious toxicity and associated adverse effects like neurotoxicity and nephrotoxicity [5]. Because of all the associated side effects and failure of drug treatment therapy, alternate treatment approach is required. Recently, an alternate treatment is known as biofield energy and is reported that inhibits the growth of bacterial cultures [6].

Enterobacter aerogenes (E. aerogenes) is a common organism of most of the hospital-acquired infections. Adaptive capability of E. aerogenes is remarkable and can easily acquire resistance to against β-lactam antibiotics [1]. During last five years, it has shown that E. aerogenes isolates are having natural resistance against aminopenicillins, and express an extended-spectrum -lactamase (ESBL), which results resistance to β-lactam antibiotics [2]. However, E. aerogenes exhibits acquired resistance against different categories of antimicrobial agents.

General resistance mechanisms exhibited by E. aerogenes involves membrane permeability, p-glycoprotein efflux pump, and enzyme degradation against carbapenems, fluoroquinolones, quinolones, tetracycline, and chloramphenicol [3]. Currently, colistin, and polymyxin antibiotic have been preferred as alternative drugs against Gram-negative pathogens, due to the extended resistance of Gramnegative bacteria against almost all antibiotics [4]. Recently, colistin in antibiotic therapy shows serious toxicity and associated adverse effects like neurotoxicity and nephrotoxicity [5]. Because of all the associated side effects and failure of drug treatment therapy, alternate treatment approach is required. Recently, an alternate treatment is known as biofield energy and is reported that inhibits the growth of bacterial cultures [6].

After consideration of the clinical significance of E. aerogenes and significant impact of Mr. Trivedi’s biofield treatment on microbes, authors evaluated the effect of biofield treatment on E. aerogenes followed by genotyping of treated organism. Genotyping was performed using strain differentiation and distinctive polymorphism using polymerase chain reaction (PCR) technique of random amplified polymorphic DNA analysis (RAPD) and 16S rDNA sequencing.

Materials and Methods

Enterobacter aerogenes ATCC 13048 [American Type Culture Collection] was procured from Bangalore Genei, in sealed pack, and stored as per the recommended storage conditions for further use. The anti-microbial susceptibility, biochemical reactions, and biotype number were evaluated on MicroScan Walk-Away® (Dade Behring Inc., West Sacramento, CA) using Negative Breakpoint Combo 30 (NBPC 30) panel. DNA fingerprinting (RAPD) and the 16S rDNA sequencing studies were carried out using Ultrapure Genomic DNA Prep Kit; Cat KT 83 (Bangalore Genei, India). All the tested antimicrobials, biochemicals and other reagents were procured from Sigma-Aldrich, India.

Study design and biofield treatment

E. aerogenes strain was divided into two groups i.e. control and treatment. The treatment group was in sealed pack and handed over to Mr. Trivedi for biofield treatment under laboratory conditions. Mr. Trivedi provided the treatment through his energy transmission process to the treated group without touching the sample. After treatment, control and treated groups were assessed on day 10 for antimicrobial susceptibility, minimum inhibitory concentration (MIC), biochemical reactions, biotype, and genotyping using RAPD and 16S rDNA analysis. The results of treated samples were compared with respect to control.

Investigation of antimicrobial susceptibility assay

Investigation of antimicrobial susceptibility of E. aerogenes was carried out with the help of automated instrument, MicroScan Walk- Away® using Negative Breakpoint Combo 30 (NBPC30) panel as per the manufacturer’s instructions. The panel was allowed to equilibrate to room temperature prior to rehydration. All opened panel were used on the same day. The tests were carried out on MicroScan, which were miniaturized of the broth dilution susceptibility test that has been dehydrated. Briefly, 0.1 mL (100 μL) of the standardized suspension of E. aerogenes was pipetted into 25 mL of inoculum water using pluronic and inverted 8-10 times and inoculated, rehydrated, and then subjected to incubation for 16 hours at 35°C. Rehydration and inoculation was performed using the RENOK® system with inoculators-D (B1013-4). The detailed experimental procedures and conditions were followed as per the manufacturer’s instructions. Briefly, after inoculation and rehydration with a standardized suspension of E. aerogenes, it was incubated at 35°C for 16 hours. MIC and a qualitative susceptibility like susceptible (S), intermediate (I), inducible β-lactamases (IB), and resistant (R) were determined by observing the lowest antimicrobial concentration showing growth inhibition [7-22].

Biochemical studies: The biochemical reactions of E. aerogenes were determined by MicroScan Walk-Away® system, it interprets the microbe biochemical results with the use of a photometric or fluorogenic reader. On the basis of nature of bacilli (Gram-negative or Gram-positive), it generates computerized reports using conventional panels, which utilizes the photometric reader and provide identification results. Before commencing the experiment, the NBPC 30 panel was first incubated and read on the MicroScan Walkaway system. After completion of reading on the Walkaway system, the NBPC 30 panel was removed from system and read on the Biomic system within 1 hour. MicroScan Walk-Away instrument consist of a database associated with collective information, which was required to identify the group, genera, or species of the family. Detailed experimental procedure was followed as per manufacturer-recommended instructions [22].

Biotype number: The biotype number of E. aerogenes was determined by MicroScan Walk-Away® processed panel data utilizing data of biochemical reactions. Similar experimental procedure was followed for identification of biotype number as described in biochemical reaction study, and as per manufacturer-recommended instructions [22].

Random Amplified Polymorphic DNA (RAPD) analysis

Three series of inoculums (one for control and other two for treatment named as treatment A and B) were prepared from E. aerogenes sample. Two inoculums (treatment samples A and B) were subjected to Mr. Trivedi’s biofield treatment. Whilst handing over treated groups to Mr. Trivedi for biofield treatment, optimum precautions were taken to avoid the contamination. After that, the treated samples (A and B) were sub-cultured by taking 1% inoculum and inoculated to fresh 5 mL medium and labeled as treatment A-1 and treatment B-1 respectively. Control and treated samples were incubated at 37°C with 160 rpm for 18 h. Subsequently, the cultures were spun down, and genomic DNA was isolated for control and treated samples using Genomic DNA Prep Kit (Bangalore Genei, India). Designed primers were initially screened for their sharpness, further primers that have the basic of sharpness, clarity of the profile and the existence of polymorphisms were chosen for further study. RAPD was performed with all samples of E. aerogenes using five RAPD primers, which were labelled as RBA8A, RBA13A, RBA20A, RBA10A and RBA15A. The PCR mixture contained 2.5 μL each of buffer, 4.0 mM each of dNTP, 2.5 μM each of primer, 5.0 μL each of genomic DNA, 2U each of Taq polymerase, 1.5 μL of MgCl2 and 9.5 μL of nuclease-free water in a total of 25 μL mixture. PCR amplification protocol followed with initial denaturation at 94ºC for 7 min, followed by 8 cycles of denaturation at 94ºC for 1 min, annealing at 35ºC for 1 min, and extension at 72ºC for 2 min; and 35 cycle of denaturation at 94ºC for 1 min, annealing at 38ºC for 1 min, and extension at 72ºC for 1.5 min; and the final extension at 72ºC for 7 min. Amplified PCR products (12 μL) from all samples (control and treated) were separated on 1.5% agarose gels at 75 volts, stained with ethidium bromide and visualized under UV illumination [23].

The percentage of polymorphism was calculated using following equation-

Percent polymorphism = A/B×100;

Where, A = number of polymorphic bands in treated sample; and B = number of polymorphic bands in control.

Amplification and gene sequencing of 16S rDNA

Genomic DNA was isolated and purified from a treated group of E. aerogenes cells by using genomic purification Kit, as per the manufacturer’s instructions. The PCR product was bi-directionally sequenced using the forward, reverse, and an internal primer. DNA 16S region amplification was performed using the primer set 16S forward and reverse primer [24]. 16S rDNA gene (~1.5 kb) was amplified by universal primers; forward primer (5image-AGAGTTTGATCCTGGCTCAG-3image) and reverse primer (3image-ACGGTCATACCTTGTTACGACTT-5image). Amplification was carried out in a Rapid Cycler thermocontroller, with initial denaturation, annealing and extension temperature. Following amplification products were analyzed by gel electrophoresis at 100 V (in 1.0% agarose gel, 0.2 μg of ethidium bromide ml-1) in tris-acetate buffer (TAE), and visualized under UV light in a gel documentation unit (BioRad Laboratories, USA). The amplified fragment of PCR was purified from the agarose gel by DNA Gel Extraction Kit. Sequencing of amplified product was carried out on a commercial basis from Bangalore Genei, India. The obtained 16S rDNA sequences data were aligned and compared with the sequences, available in GenBank database of National Center for Biotechnology Information (NCBI) using the algorithm BLASTn program. The multiple sequence alignment/ phylogenetic tree were constructed using MEGA 3.1 software using neighbor-joining method [25].

Results and Discussion

Assessment of antimicrobial susceptibility

The effect of biofield treatment on E. aerogenes with respect to antimicrobials susceptibility pattern and MIC are summarized in Tables 1 and 2, respectively. The data were analyzed and compared with respect to control. The treated cells of E. aerogenes showed 14.28% alteration out of twenty-eight tested antimicrobials as compared to control. Results showed altered antibiogram of cefotaxime, cefotetan, chloramphenicol, and piperacillin as compared to control. Cefotaxime was converted from inducible β-lactamases to intermediate, while cefotetan changed from inducible β-lactamases to resistant. Chloramphenicol resistance profile was improved from resistant to susceptible as compared to control. Piperacillin sensitivity was also altered from inducible β-lactamases to intermediate. Rest of the tested antimicrobials did not show any alteration in sensitivity with respect to control.

S. No. Antimicrobial Control Treated
1. Amikacin S S
2. Amoxicillin/k-clavulanate R R
3. Ampicillin/sulbactam I I
4. Ampicillin R R
5. Aztreonam IB IB
6. Cefazolin R R
7. Cefepime S S
8. Cefotaxime IB I
9. Cefotetan IB R
10. Cefoxitin R R
11. Ceftazidime IB IB
12. Ceftriaxone IB IB
13. Cefuroxime IB IB
14. Cephalothin R R
15. Chloramphenicol R S
16. Ciprofloxacin S S
17. Gatifloxacin S S
18. Gentamicin S S
19. Imipenem S S
20. Levofloxacin S S
21. Meropenem S S
22. Moxifloxacin S S
23. Piperacillin/tazobactam IB IB
24. Piperacillin IB I
25. Tetracycline S S
26. Ticarcillin/k-clavulanate IB IB
27. Tobramycin S S
28. Trimethoprim/sulfamethoxazole S S

Table 1: Effect of biofield treatment on multidrug resistant lab isolates of Enterobacter aerogenes to antimicrobial susceptibility.

S. No. Antimicrobial Control Treated
1. Amikacin ≤16 ≤16
2. Amoxicillin/K-clavulanate >16/8 >16/8
3. Ampicillin/sulbactam 16/8 16/8
4. Ampicillin >16 >16
5. Aztreonam ≤8 ≤8
6. Cefazolin >16 >16
7. Cefepime ≤8 ≤8
8. Cefotaxime ≤8 32
9. Cefotetan ≤16 >32
10. Cefoxitin >16 >16
11. Ceftazidime ≤8 ≤8
12. Ceftriaxone ≤8 ≤8
13. Cefuroxime ≤4 ≤4
14. Cephalothin >16 >16
15. Chloramphenicol >16 ≤8
16. Ciprofloxacin ≤1 ≤1
17. ESBL-a Scrn ≤4 ≤4
18. ESBL-b Scrn ≤1 ≤1
19. Gatifloxacin ≤2 ≤2
20. Gentamicin ≤4 ≤4
21. Imipenem ≤4 ≤4
22. Levofloxacin ≤2 ≤2
23. Meropenem ≤4 ≤4
24. Moxifloxacin ≤2 ≤2
25. Nitrofurantoin 64 64
26. Norfloxacin 8 ≤4
27. Piperacillin/tazobactam ≤16 ≤16
28. Piperacillin ≤16 64
29. Tetracycline ≤4 ≤4
30. Ticarcillin/k-clavulanate ≤16 ≤16
31. Tobramycin ≤4 ≤4
32. Trimethoprim/sulfamethoxazole ≤2/38 ≤2/38

Table 2: Minimum inhibitory concentration (MIC) of tested antimicrobials against Enterobacter aerogenes.

Similarly, sensitivity results of tested antimicrobials are well supported with MIC results (Table 2). Cefotaxime showed four folds alteration in MIC value (32 μg/mL) while cefotetan showed two folds change in MIC value (>32 μg/mL) with respect to control. Improved sensitivity of chloramphenicol also showed decreased MIC value by two folds (i.e. >16 to ≤8 μg/mL) as compared to control. Norfloxacin also a showed decrease in MIC value by two folds after biofield treatment with respect to control (i.e. 8 to ≤4 μg/mL). However, piperacillin showed four folds change in MIC value (i.e. ≤16 to 64 μg/mL) as compared to control. Overall, 15.65% tested antimicrobials showed altered MIC values with respect to control. The rest of the tested antimicrobials did not show any alteration in MIC values with respect to control data.

According to National health statistics reports of National Center for Health Statistics in the Unites States, 2002-2012, biofield treatment as an alternative energy medicine was well reported and practiced among adults [26]. The current experiment was designed to demonstrate the impact of biofield treatment on E. aerogenes for its susceptibility pattern, biochemical reaction, and biotype number. Further, molecular methods were performed to study the genetic alterations and similarities using RAPD and 16S rDNA sequencing methods. Increased emergence of resistant E. aerogenes is a global health problem, as an emerging Gram-negative pathogen in Enterobacteriaceae family, associated with severe hospital acquired infections. E. aerogenes isolates have a broad ability to develop antimicrobial resistance [27]. Results showed, biofield treatment has induced change in susceptibility pattern of antimicrobials such as cefotaxime, cefotetan, chloramphenicol, and piperacillin as compared to control. Chloramphenicol showed improved sensitivity after biofield treatment from resistant to susceptible. Chloramphenicol exhibited natural resistance against E. aerogenes, and it was mediated either enzymatically through acetylation of the drug or mechanically via active drug efflux [28]. Moreover, general resistance mechanism involves in Enterobacter sp. against tetracycline, fluoroquinolones and chloramphenicol through efflux mechanism to expel the antimicrobials [3]. Biofield treatment on E. aerogenes showed improved susceptibility of chloramphenicol, which suggested that biofield treatment might acetylate the chloramphenicol molecule. Improved sensitivity might be correlated with acetylation that may happen via active drug efflux mechanism as compared to control.

significant decreased MIC value of chloramphenicol with increased antimicrobial sensitivity was reported with respect to control. Increased incidence of nosocomial infections and broad resistance to third generation cephalosporins, penicillins and quinolones are a serious problem. However, fourth generation antimicrobials remain effective for treatment but with serious side effects [29]. Aminoglycosides, quinolones, trimethoprim/sulphamethoxazole, and carbapenems displayed good activity against Gram-negative pathogens including Enterobacter species [30]. Mr. Trivedi’s biofield treatment showed a significant decrease in MIC values of chloramphenicol and norfloxacin, which suggested an alteration at enzymatic/genetic level. Alterations might affect the β-lactamases production that may lead to decrease the MIC, which is required to inhibit the growth of E. aerogenes.

Organism identification by biochemical reactions

The biochemical reactions of E. aerogenes are presented in Table 3. Overall, 9.09% biochemical reactions were altered out of thirtythree tested biochemicals. In the present study, nitrate and Voges- Proskauer biochemicals showed negative reaction i.e. positive (+) to negative (-) as compared to control. However, kanamycin showed positive reaction i.e. negative (-) to positive (+) with compared to control. Rest of thirty biochemicals did not show any alteration in metabolic reactions with respect to control. Different phenotypic identification tests were available to differentiate the Enterobacter species. Experimental identification of E. aerogenes was performed using a series of biochemical reactions. Enterobacter species have basic characteristic reactions such as the presence of Voges-Proskauer, sucrose, dextrose, glucose, lactose, rhamnose, citrate, lysine, ornithine decarboxylase, and motile in nature. Indole, methyl red and hydrogen sulphide are the negative characteristic tests of Enterobacter species. Biochemical reactions tested in the control group were well supported with literature data [31,32]. Biofield treatment might involve some enzymatic alterations in E. aerogenes, which resulted in alterations in characteristic biochemical reactions.

S. No. Code Biochemical Control Treated
1. ACE Acetamide - -
2. ADO Adonitol + +
3. ARA Arabinose + +
4. ARG Arginine - -
5. CET Cetrimide - -
6. CF8 Cephalothin + +
7. CIT Citrate + +
8. CL4 Colistin - -
9. ESC Esculin hydrolysis + +
10. FD64 Nitrofurantoin - -
11. GLU Glucose + +
12. H2S Hydrogen sulfide - -
13. IND Indole - -
14. INO Inositol + +
15. K4 Kanamycin - +
16. LYS Lysine + +
17. MAL Malonate + +
18. MEL Melibiose + +
19. NIT Nitrate + -
20. OF/G Oxidation-Fermentation + +
21. ONPG Galactosidase + +
22. ORN Ornithine + +
23. OXI Oxidase - -
24. P4 Penicillin + +
25. RAF Raffinose + +
26. RHA Rhamnose + +
27. SOR Sorbitol + +
28. SUC Sucrose + +
29. TAR Tartarate + +
30. TDA Tryptophan Deaminase - -
31. TO4 Tobramycin - -
32. URE Urea - -
33. VP Voges-Proskauer + -

Table 3: Effect of biofield treatment on multidrug resistant lab isolates of Enterobacter aerogenes to the vital processes occurring in living organisms.

Organism identification by biotype number

E. aerogenes was identified based on a variety of conventional biochemical characters and biotyping. After interpreting the results of the biochemical reactions, biotype number of E. aerogenes was evaluated using automated Microscan system. The biotype number then led to the organism identification. In this experiment, biotyping was performed, and results found a significant change in biotype number (7770 5272) in treated group as compared to control (7770 5372). Organism identified in both the groups was same as E. aerogenes. Our research group recently reported the significant alterations in biochemical reactions followed by the change in biotype number that also supported with published data [18-20].

Random Amplified Polymorphic DNA (RAPD) analysis

Treated and control samples were identified on the basis of their different and discriminative RAPD patterns. RAPD is a new tool that is being used now a days to correlate the genetic similarity or mutations between species. The simplicity and wide applicability of RAPD analysis mainly depend on the use of short nucleotide primers, which were unrelated to known DNA sequences of the target organism [33]. DNA polymorphism can be efficiently detected using PCR primers and identify interstrain variations among species in treated samples [34]. The degree of relatedness and genetic mapping can be correlated between similar or different treated sample species [35].

Random amplified polymorphic-DNA fragment patterns of E. aerogenes control, and treated samples were generated using five RAPD primers and shown in Figure 1, with 100 base pair (bp) of DNA ladder. The polymorphic bands in control and treated samples are marked by arrows. The RAPD patterns of treated samples showed some unique and dissimilar bands among control and treated samples. DNA polymorphism analyzed by RAPD analysis, total number of bands, common, and unique bands were summarized in Table 4. The level of polymorphism between control and treated samples (A, A1, B, and B1) are summarized in Table 5. The level of polymorphism was found in an average range of 4 to 42% in treated samples as compared to control, while 6 to 31% among treated samples of E. aerogenes after the biofield treatment. The highest change (70%) in DNA sequence was observed in treated groups with RBA 10A primer as compared to the control; however no change was found in treated group (control and A1,B, and B1; B and B1, A1 and B1) with RBA 8A primer as compared to the control. Likewise, RBA13A and RBA20A also showed no polymorphism between control and treated samples of E. aerogenes after the biofield treatment (Table 5). In the present exploration, difference of polymorphic bands DNA were visualized and scored accordingly. Most of the polymorphic bands shown in the gel image were more than 500 bp, while some bands were reported to have around 150 and 250 bp. The primer RBA10A, showed three and four polymorphic bands (marked by arrow) in control and treated (A and B), while RBA20A showed five polymorphic bands in treated samples (A and B) only.

translational-medicine-amplified-polymorphic-fragment

Figure 1: Random amplified polymorphic-DNA fragment patterns of Enterobacter aerogenes generated using five RAPD primers, RBA 8A, RBA 13A, RBA 20A, RBA 10A and RBA 15A.

S. No. Primer Nucleotide sequence (5’-3’) Bands scored Common bands in control and treated Unique band
Control TSA TSA-1 TSB TSB-1
1. RBA 8A GTTTCGCTCC 15 7 - 1 - - -
2. RBA 13A GTGGATCCGA 14 10 - 2 - - -
3. RBA 20A GCGATCCCCA 12 7 - 1 - 1 1
4. RBA 10A CCGCAGCCAA 13 1 - - - - -
5. RBA 15A AAGAGCCCGT 11 8 - 1 - - -

Table 4: DNA polymorphism analyzed by random amplified polymorphic DNA (RAPD) analysis.

Primer C and TSA C and TSA-1 C and TSB C and TSB-1 TSA and TSA-1 TSB and TSB-1 TSA and TSB TSA-1 and TSB-1
RBA 8A 33% 0% 0% 0% 25% 0% 33% 0%
RBA 13A 30% 0% 10% 0% 30% 9% 20% 0%
RBA 20A 41% 0% 50% 0% 45% 45% 11% 0%
RBA 10A 70% 30% 70% 0% 40% 44% 0% 30%
RBA 15A 40% 20% 20% 20% 18% 0% 20% 0%
Average polymorphism 42.8% 10% 30% 4% 31.6% 19.6% 16.8% 6%

Table 5: Level of polymorphism between control and treated samples after biofield treatment.

16S rDNA genotyping

Molecular PCR assay based on 16S rDNA amplification protocol using standard forward and reverse 16S universal primers have been commonly used as a taxonomic “gold standard” in identification and determining the phylogenies of bacterial species [36]. 16S rDNA sequencing was performed in biofield treated E. aerogenes to identify the other closely related species of treated sample. The alignment and comparison of the gene sequences were performed with the sequences stored in Gen Bank database available from NCBI using the algorithm BLASTn program. Based on nucleotides homology and phylogenetic analysis the Microbe (Sample 8A) was closely detected as genus-species to Kluyvera cryocrescens (GenBank Accession Number: AM184245) with 97% identity, which was nearest homolog genus-species to Enterobacter aerogenes (Accession No. AB244467). The closest sequences of E. aerogenes obtained from sequence alignment using NCBI GenBank and ribosomal database project (RDP) was presented in Table 6. Distance matrix based on nucleotide sequence homology (Using Kimura-2 Parameter) indicates nucleotide similarity and distance identities between sample ‘8A’ and other ten closest homologs microbe of E. aerogenes was calculated and shown in Table 7. Phylogenetic tree of the partial 16S rDNA gene sequencing using MEGA 3.1 software by neighbor joining method are presented in Figure 2, ten closely related bacterial species as Operational Taxonomic Units (OTUs) in order to investigate the phylogenetic relationship of E. aerogenes among other ten other bacterial species. There were 1486 base nucleotides of 16S rDNA gene sequences were analyzed and multiple alignment were constructed using ClustalW in MEGA 3.1 software [25]. According to the data in Table 7, the lowest value of the genetic distance from E. aerogenes was 0.031 base substitutions per site. All pairwise distance analysis was carried out using the p-distance method in MEGA 3.1. The proportion of remarked distance, sometimes also called p-distance and showed as the number of nucleotide distances site. Values in Table 7 were programmed into Figure 2 with optimal bootstrap consensus tree. In the phylogram, there were eleven OTUs. Based on the phylogenetic tree and 16S rDNA sequencing, the nearest homolog genus-species was found to be E. aerogenes.

Alignment View ID Alignment results Sequence description
image 8A 0.87 Sample studied
image AB244467 0.99 Enterobacteraerogenes strain: C1111
image AB244456 0.98 Enterobacteraerogenes strain: An19-2
image AB244445 0.98 Enterobacteraerogenes strain: An10-1
image AJ251468 0.98 Enterobacteraerogenes strain NCTC10006T
image AB244472 0.97 Enterobacteraerogenes strain: NC4211
image AB244302 0.97 Enterobacteraerogenes strain: A13-1
image EU304255 0.98 Pantoeaagglomerans
image Y17666 0.98 Klebsiellaornithinolytica strain FSK9555
image Y17670 0.99 Klebsiellaterrigena strain SW4
image AM184245 0.97 Kluyveracryocrescens strain WAB1904

Table 6: The closest sequences of Enterobacter aerogenes from sequence alignment using NCBI GenBank and ribosomal database project (RDP).

Distance Matrix
AN   1 2 3 4 5 6 7 8 9 10 11
AB244445 1 0.999 1 0.987 1 0.992 1 0.988 0.992 0.999 0.972
AB244302 2 0.001 0.999 0.987 0.999 0.992 0.999 0.987 0.992 1 0.971
AB244456 3 0.000 0.001 0.987 1 0.992 1 0.988 0.992 0.999 0.972
EU304255 4 0.013 0.013 0.013 0.987 0.989 0.987 0.999 0.987 0.987 0.965
AJ251468 5 0.000 0.001 0.000 0.013 0.992 1 0.988 0.992 0.999 0.972
Y17666 6 0.008 0.009 0.008 0.011 0.008 0.992 0.990 0.990 0.992 0.971
AB244467 7 0.000 0.001 0.000 0.013 0.000 0.008 0.988 0.992 0.999 0.972
Y17670 8 0.012 0.013 0.012 0.001 0.012 0.010 0.012 0.987 0.987 0.966
AM184245 9 0.008 0.009 0.008 0.013 0.008 0.010 0.008 0.013 0.992 0.969
AB244472 10 0.001 0.000 0.001 0.013 0.001 0.009 0.001 0.013 0.009 0.971
8A 11 0.028 0.029 0.028 0.035 0.028 0.029 0.028 0.034 0.031 0.029

Table 7: Distance matrix based on nucleotide sequence homology (Using Kimura-2 Parameter) indicates nucleotide similarity (above diagonal) and distance (below diagonal) identities between the studied sample ‘8A’ and ten closest homologs microbe.

translational-medicine-phylogenetic-gene-software

Figure 2: Phylogenetic tree of the partial 16S rDNA gene sequencing using MEGA 3.1 software by Neighbor joining method. Numbers represent GenBank accession number

Conclusion

Based on these results, it can be concluded that biofield treatment has the significant impact in altering the sensitivity of antimicrobials against E. aerogenes. Mr. Trivedi’s biofield energy treatment on E. aerogenes showed improved the sensitivity of resistant chloramphenicol, while decreased MIC value by two folds, in case of chloramphenicol and norfloxacin against E. aerogenes as compared to control. Biochemical reactions were also altered followed by change in biotype number after biofield treatment. Using RAPD markers, the sample was characterized and showed 4 to 42% interspecific polymorphic relationship with E. aerogenes after biofield treatment. Molecular method using 16S rDNA analysis showed that sample detected as Kluyvera cryocrescens with 97% identity, which was nearest homolog species to Enterobacter aerogenes. Overall, it seems that Mr. Trivedi’s unique biofield treatment might be used as an alternate treatment approach in future than the existing antimicrobial therapy.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Recommended Conferences

Article Usage

  • Total views: 12784
  • [From(publication date):
    December-2015 - Jun 24, 2018]
  • Breakdown by view type
  • HTML page views : 8988
  • PDF downloads : 3796
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7